Oligometastatic Prostate Cancer: Current Management Strategies
摘要
Oligometastatic prostate cancer (OMPC) consists of a heterogeneous group of cancer, defined by number and more recently by volume of the metastatic lesions. The distinct biology and improved outcome in OMPC have sparked increasing interest in this area. Metastasis-directed therapy (MDT), in addition to standard of care (SOC), improves local control and progression-free survival (PFS) and maintains quality of life (QoL). In this chapter, will we discuss the management strategies for patients with OMPC.